Actively Recruiting
Trial of Xylitol Chewing Gum to Prevent Periodontal Disease and Reduce Preterm Birth in Pregnant Individuals in Malawi
Led by University of Washington · Updated on 2026-09-10
6000
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a clinical trial in Malawi to study the effects of xylitol-containing chewing gum on preventing maternal periodontal disease, preterm birth, and low birthweight babies in pregnant individuals. This study builds on previous research that found a link between maternal gum disease and early birth, aiming to improve outcomes with an optimized xylitol dose and to assess infant neurodevelopment and mortality. Participants are randomly assigned to one of three groups chewing xylitol gum at 6.4 grams daily, chewing xylitol gum at 2.1 grams daily, or chewing a placebo gum made of flavored sorbitol without xylitol. They will start the gum chewing before 20 weeks of pregnancy and continue until delivery, chewing two pieces three times a day for five minutes each time. The study is double-blind and placebo-controlled to ensure unbiased results. During the trial, participants will attend multiple study visits and undergo dental exams with microbiota sampling at early pregnancy, late pregnancy, and postpartum. Biospecimens will be collected for later analysis of inflammation and microbiome changes. The trial will also monitor birth outcomes such as preterm birth and low birthweight, track infant mortality and developmental progress up to one year, and assess maternal gum health through pregnancy and after birth.
CONDITIONS
Brief Title
Xylitol and the Prevention of Periodontal Disease and Preterm Birth Trial
Research Team
G
Greg Valentine, MD MED FAAP
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here